Equimolar Production of Amyloid Beta-protein and Amyloid Precursor Protein Intracellular Domain from Beta-carboxyl-terminal Fragment by Gamma-secretase
Overview
Authors
Affiliations
We showed previously that cells expressing wild-type (WT) beta-amyloid precursor protein (APP) or coexpressing WTAPP and WT presenilin (PS) 1/2 produced APP intracellular domains (AICD) 49-99 and 50-99, with the latter predominating. On the other hand, the cells expressing mutant (MT) APP or coexpressing WTAPP and MTPS1/2 produced a greater proportion of AICD-(49-99) than AICD-(50-99). In addition, the expression of amyloid beta-protein (Abeta) 49 in cells resulted in predominant production of Abeta40 and that of Abeta48 leads to preferential production of Abeta42. These observations suggest that epsilon-cleavage and gamma-cleavage are interrelated. To determine the stoichiometry between Abeta and AICD, we have established a 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid-solubilized gamma-secretase assay system that exhibits high specific activity. By using this assay system, we have shown that equal amounts of Abeta and AICD are produced from beta-carboxyl-terminal fragment (C99) by gamma-secretase, irrespective of WT or MTAPP and PS1/2. Although various Abeta species, including Abeta40, Abeta42, Abeta43, Abeta45, Abeta48, and Abeta49, are generated, only two species of AICD, AICD-(49-99) and AICD-(50-99), are detected. We also have found that M233T MTPS1 produced only one species of AICD, AICD-(49-99), and only one for its counterpart, Abeta48, in contrast to WT and other MTPS1s. These strongly suggest that epsilon-cleavage is the primary event, and the produced Abeta48 and Abeta49 rapidly undergo gamma-cleavage, resulting in generation of various Abeta species.
Recording γ-secretase activity in living mouse brains.
Hou S, Ikegawa Y, Kwon Y, Wieckiewicz N, Houser M, Lundin B Elife. 2024; 13.
PMID: 39360803 PMC: 11449482. DOI: 10.7554/eLife.96848.
Sato W, Watanabe-Takahashi M, Murata T, Utsunomiya-Tate N, Motoyama J, Anzai M Commun Biol. 2023; 6(1):383.
PMID: 37031306 PMC: 10082830. DOI: 10.1038/s42003-023-04771-9.
Schmidt F, Fitz K, Feilen L, Okochi M, Steiner H, Langosch D J Biol Chem. 2023; 299(5):104626.
PMID: 36944398 PMC: 10164903. DOI: 10.1016/j.jbc.2023.104626.
Mass Spectrometry Imaging in Alzheimer's Disease.
Ikegawa M, Kakuda N, Miyasaka T, Toyama Y, Nirasawa T, Minta K Brain Connect. 2023; 13(6):319-333.
PMID: 36905365 PMC: 10494909. DOI: 10.1089/brain.2022.0057.
Svedruzic Z, Sendula Jengic V, Ostojic L Int J Mol Sci. 2023; 24(3).
PMID: 36768156 PMC: 9915333. DOI: 10.3390/ijms24031835.